China Lianyungang Jinkang Hexin Pharmaceutical Co Ltd. specialiter in L-5-Methyltetrahydrofolata ab 2007.
Anno 2012, Jinkang Pharmaceuticae mundi purissimae et firmissimae L-5-Methyltetrahydrofolatae Calcium Crystallinum patente productum elaboraverunt, trademark Magnafolate®, US Patent 9,150,982 B2, Patent Unionis Europaeae No. EP2805952B1, quod in Canada, Australia producitur. ac eleifend.
Ex MMXII ad 2016, Goldcom Hutchinsonus patentes magnafolatas per orbem terrarum applicavit et descripserunt. Nunc Jinkang Hesin maximas patentes Calcii coetus L-5-Methyltetrahydrofolatae in mundo possidet.
Nunc JKHX factus est 1 effector Calcii L-5-Methyltetrahydrofolati in Sinis, et plus usus est in educendo in Americam Septentrionalem, Europam, Brasiliam et alia loca.
L-5-Methyltetrahydrofolatum Calcium Ingredient Utilitas:
US FDA NDI 920 registration
Gras auto-affirmavit
Patented C-Crystallinus Calcium Salt
Summum gradum L-5-methyltetrahydrofolatum (>85)
Stabilis ad cella temperies pro 3 annis, etiam in zona IVB .
Kosher, Halal, ISO22000.
Licentia Ciborum Fabricatio, etc.
In conclusione, Calcium L-5-Methyltetrahydrofolatum magnum est supplementum nutritionis et medicamentum pharmaceuticum, et magni momenti est eligere certum supplementum.
Magnafolate® calcii L-5-methyltetrahydrofolati tutior, purior, stabilior et aptus est amplis hominibus in iis cum mutationum generum MTHFR. Calcium L-5-methyltetrahydrofolatum non indiget metabolisi in corpore et immediate absorberi potest.

Español
Português
русский
Français
日本語
Deutsch
tiếng Việt
Italiano
Nederlands
ภาษาไทย
Polski
한국어
Svenska
magyar
Malay
বাংলা ভাষার
Dansk
Suomi
हिन्दी
Pilipino
Türkçe
Gaeilge
العربية
Indonesia
Norsk
تمل
český
ελληνικά
український
Javanese
فارسی
தமிழ்
తెలుగు
नेपाली
Burmese
български
ລາວ
Latine
Қазақша
Euskal
Azərbaycan
Slovenský jazyk
Македонски
Lietuvos
Eesti Keel
Română
Slovenski
मराठी
Srpski језик 







Online Service